Company research / SUPN
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, SUPERNUS PHARMACEUTICALS, INC. reported revenue of $718.95M. Revenue grew 8.6% from the prior annual period.
Key ratios (year ended 2025-12-31)
-8.7%
Operating margin
-5.4%
Net margin
-3.6%
Return on year-end equity
8.6%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.